
Wisp Names Jennifer Peña as Chief Medical Officer to Support Integrated Women's Telehealth
NEW YORK--(BUSINESS WIRE)-- Wisp, the largest pure play women's telehealth company in the U.S. focused on providing sexual and reproductive health solutions to more than 1.5 million customers, today announced the appointment of Jennifer Peña, MD, as the company's Chief Medical Officer. Dr. Peña will have a crucial role in driving Wisp's commitment to being the one-stop-shop for all women's health needs, as the company continues to scale new and existing offerings.
As CMO, Dr. Peña will spearhead Wisp's clinical strategy, quality, and safety programs, aligning telehealth operations with the company's broader business goals. She will oversee clinical care delivery, ensuring regulatory compliance and high standards of patient care, while guiding product development and expanding protocols for new verticals. Dr. Peña will mentor and grow a multidisciplinary clinical team, establish KPIs to benchmark performance, and collaborate cross-functionally to integrate clinical insight into Wisp's innovation and execution. As a clinical expert, she will serve as a key advisor to internal and external stakeholders as Wisp accelerates its growth.
'Wisp is committed to delivering clinical excellence and expanding access to high-quality care for women nationwide,' said Monica Cepak, CEO of Wisp. 'We have already built a trusted platform serving over 1.5 million women to meet all of their health needs. As we continue to grow and remain the leading one-stop shop for women's health, Dr. Peña's clinical expertise, across traditional clinics and telehealth, will help us push the boundaries of what's possible in virtual care. Her leadership will be crucial in building the next chapter of Wisp as we double down on our commitment to bringing innovation, accessibility, and quality care into the women's health space.'
Dr. Peña brings 20 years of clinical and leadership experience across the healthcare ecosystem. As a board-certified internal medicine physician, she previously served as Medical Director for Oscar Health and Chief Medical Officer for Nurx, K Health, and Vault Health, where she led teams that delivered high-quality, tech-enabled care to diverse populations. Before that, she served as a U.S. Army physician and White House physician. Dr. Peña earned her MD from the University of Pittsburgh School of Medicine and her undergraduate degree from Yale University.
'Wisp is redefining access to sexual and reproductive health with clinical excellence and unmatched convenience,' said Dr. Jennifer Peña, Chief Medical Officer at Wisp. 'I'm thrilled to join a company that is breaking down barriers and reimagining what care looks like, whether that's delivering at-home STI testing, affordable BV treatment, effective UTI prevention or evidence-based menopause support. We're not just offering telehealth; we're building a movement to destigmatize women's health and set a new, human-centered standard for virtual care."
ABOUT WISP:
Wisp is the largest pure play women's telehealth company in the U.S. focused on providing sexual and reproductive health solutions to its more than 1.4 million patients in all 50 states. Offering discreet treatments online with a comprehensive selection of first-to-market products and telehealth services, Wisp has solidified itself as the one-stop shop for all women's health needs.
Wisp is committed to making women's healthcare more inclusive, cost-effective, and accessible for all, addressing all stages of her healthcare journey, from her birth control, to fertility, menopause, STI diagnostics, weight care and more. Wisp has been named Fast Company's Most Innovative Companies of 2023 and Inc.'s Best in Business in 2024. Wisp is a growing and profitable company and is majority-owned by WELL Health Technologies Corp. To learn more, please visit hellowisp.com or follow @hellowisp on Facebook, Instagram, TikTok and YouTube.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
26 minutes ago
- Business Wire
Vestis Corporation (VSTS) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Vestis Corporation ('Vestis' or the 'Company') (NYSE: VSTS) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN VESTIS CORPORATION (VSTS), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? On May 7, 2025, Vestis released its second quarter fiscal 2025 financial results and revised its prior growth and revenue guidance for 2025, providing guidance for the third quarter, falling significantly below market expectations. The Company explained that the poor results were partially due to 'lost business in excess of new business' but primarily on 'lower adds over stops, which is how [it] describe[s] volumes changes with [its] existing customers.' On this news, Vestis's stock price fell $3.27, or 37.5%, to close at $5.44 per share on May 7, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you purchased Vestis securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


Business Wire
33 minutes ago
- Business Wire
Sable Offshore Corp. (SOC) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Sable Offshore Corp. ('Sable' or the 'Company') (NYSE: SOC) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN SABLE OFFSHORE CORP. (SOC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at howardsmith@ by telephone at (215) 638-4847 or visit our website at What Happened? On May 19, 2025, Sable announced that it had resumed oil production from one of three offshore platforms related for its Las Flores pipelines ('Onshore Pipeline') in California. Then, on May 23, 2025, the California State Land Commission sent Sable a letter regarding its May 19th announcement, warning that it 'appears to mischaracterize the nature of recent activities, causing significant public confusion and raising questions regarding Sable's intentions,' and that Sable had conflated offshore well testing activities required by a federal regulatory agency with the restart of operations. Then, on May 28, 2025, the Santa Barbara County Superior Court approved a preliminary injunction from the California Coastal Commission regarding Sable's maintenance and repair work in the coastal zone related to the Onshore Pipeline. On this news, Sable's stock price fell $5.04, or 15.3%, to close at $27.89 per share on May 28, 2025, thereby injuring investors. Contact Us To Participate or Learn More: If you purchased Sable securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us: Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, Telephone: (215) 638-4847 Email: howardsmith@ Visit our website at: This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


Business Wire
37 minutes ago
- Business Wire
KBRA Assigns Preliminary Ratings to CROSS 2025-H5 Mortgage Trust
NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to ten classes of mortgage pass-through certificates from CROSS 2025-H5 Mortgage Trust, an RMBS transaction issued under the CROSS shelf, where Hildene in affiliation with CrossCountry Mortgage and CrossCountry Capital sponsored the transaction. The $416.5 million transaction is collateralized by a pool of 881 residential mortgages originated by CCM, including a meaningful concentration of collateral that KBRA considers to be 'non-prime', with fixed-rate mortgages (FRMs) and hybrid adjustable-rate mortgages (ARMs) making up 86.7% and 13.3% of the pool, respectively. KBRA's rating approach incorporated loan-level analysis of the mortgage pool through its Residential Asset Loss Model (REALM), an examination of the results from third-party loan file due diligence, cash flow modeling analysis of the transaction's payment structure, reviews of key transaction parties and an assessment of the transaction's legal structure and documentation. This analysis is further described in our U.S. RMBS Rating Methodology. To access ratings and relevant documents, click here. Click here to view the report. Recent Publications Methodologies Disclosures Further information on key credit considerations, sensitivity analyses that consider what factors can affect these credit ratings and how they could lead to an upgrade or a downgrade, and ESG factors (where they are a key driver behind the change to the credit rating or rating outlook) can be found in the full rating report referenced above. A description of all substantially material sources that were used to prepare the credit rating and information on the methodology(ies) (inclusive of any material models and sensitivity analyses of the relevant key rating assumptions, as applicable) used in determining the credit rating is available in the Information Disclosure Form(s) located here. Information on the meaning of each rating category can be located here. Further disclosures relating to this rating action are available in the Information Disclosure Form(s) referenced above. Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at About KBRA Kroll Bond Rating Agency, LLC (KBRA), one of the major credit rating agencies (CRA), is a full-service CRA registered with the U.S. Securities and Exchange Commission as an NRSRO. Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority. Kroll Bond Rating Agency UK Limited is registered as a CRA with the UK Financial Conduct Authority. In addition, KBRA is designated as a Designated Rating Organization (DRO) by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized as a Qualified Rating Agency by Taiwan's Financial Supervisory Commission and is recognized by the National Association of Insurance Commissioners as a Credit Rating Provider (CRP) in the U.S. Doc ID: 1009870